Walgreens Stock-Based Compensation 2010-2024 | WBA

Walgreens annual/quarterly stock-based compensation history and growth rate from 2010 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • Walgreens stock-based compensation for the quarter ending August 31, 2024 was $0.182B, a 52.73% decline year-over-year.
  • Walgreens stock-based compensation for the twelve months ending August 31, 2024 was $475M, a 61.94% decline year-over-year.
  • Walgreens annual stock-based compensation for 2024 was $0.182B, a 52.73% decline from 2023.
  • Walgreens annual stock-based compensation for 2023 was $0.385B, a 1.53% decline from 2022.
  • Walgreens annual stock-based compensation for 2022 was $0.391B, a 152.26% increase from 2021.
Walgreens Annual Stock-Based Compensation
(Millions of US $)
2024 $182
2023 $385
2022 $391
2021 $155
2020 $137
2019 $119
2018 $130
2017 $91
2016 $115
2015 $109
2014 $114
2013 $104
2012 $99
2011 $135
2010 $84
2009 $84
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $9.329B $147.658B
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $75.906B 8.08
Herbalife (HLF) Cayman Islands $0.705B 3.57
China Jo-Jo Drugstores Holdings (CJJD) China $0.013B 0.00
GNC Holdings (GNC) United States $0.000B 0.00